fluphenazine has been researched along with Idiopathic Parkinson Disease in 18 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "A double-blind, cross-over trial of the effectiveness of piribedil, procyclidine and placebo in the control of parkinsonism induced by fluphenazine decanoate was conducted in sixteen cases of chronic schizophrenia." | 5.04 | A comparison of piribedil, procyclidine and placebo in the control of phenothiazine-induced parkinsonism. ( Bradley, R; Lamb, P; Mindham, RH, 1977) |
| "Relapse was accompanied by a resurgence of specifically schizophrenic symptoms and by an increase in abnormalities described by the relatives." | 2.64 | Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial. Report to the Medical Research Council Committee on Clinical Trials in Psychiatry. ( Gaind, R; Hirsch, SR; Rohde, PD; Stevens, BC; Wing, JK, 1973) |
| "The comorbidity of schizophrenia and idiopathic Parkinson's disease (IPD) is illustrated by a case description of a schizophrenic patient who develops motor symptoms finally diagnosed and treated as comorbid IPD." | 1.40 | Clinical aspects of comorbid schizophrenia and idiopathic Parkinson's disease. ( de Jong, MH; Van Gool, AR; Zemel, D, 2014) |
| "The neuroleptic-induced catalepsy was reversed by the classical anti-parkinsonian agent L-DOPA and by agents that function through dopamine systems such as d- and methamphetamine and the direct D2 receptor agonist quinpirole." | 1.28 | Neuroleptic-induced catalepsy as a model of Parkinson's disease. I. Effect of dopaminergic agents. ( Close, SP; Elliott, PJ; Hayes, AG; Marriott, AS; Walsh, DM, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (83.33) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (5.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Jong, MH | 1 |
| Zemel, D | 1 |
| Van Gool, AR | 1 |
| KRUSE, W | 1 |
| Sheppard, C | 1 |
| Merlis, S | 1 |
| Mukherjee, S | 1 |
| Rosen, AM | 1 |
| Cardenas, C | 1 |
| Varia, V | 1 |
| Olarte, S | 1 |
| Weiner, WJ | 1 |
| Luby, ED | 1 |
| Martin, IC | 1 |
| Mindham, RH | 2 |
| Lamb, P | 1 |
| Bradley, R | 1 |
| Stimmel, GL | 1 |
| Elliott, PJ | 2 |
| Close, SP | 2 |
| Walsh, DM | 2 |
| Hayes, AG | 2 |
| Marriott, AS | 2 |
| Boelkins, RC | 1 |
| Gaind, R | 2 |
| Anstee, BH | 1 |
| Rimmer, L | 1 |
| Hirsch, SR | 1 |
| Rohde, PD | 1 |
| Stevens, BC | 1 |
| Wing, JK | 1 |
| Itil, TM | 1 |
| Patterson, CD | 1 |
| Keskiner, A | 1 |
| Holden, JM | 1 |
| Dreyfuss, J | 1 |
| Beer, B | 1 |
| Devine, DD | 1 |
| Roberts, BF | 1 |
| Schreiber, EC | 1 |
| Diemath, HE | 1 |
| Enge, S | 1 |
| Lechner, H | 1 |
| Strang, RR | 1 |
| Kurland, AA | 1 |
| Dim, BH | 1 |
| Olsson, JE | 1 |
5 trials available for fluphenazine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Implications of phenothiazine side effects: a study of antiparkinsonian agents in an older population.
Topics: Adult; Aged; Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Delayed-Action Preparat | 1975 |
A comparison of piribedil, procyclidine and placebo in the control of phenothiazine-induced parkinsonism.
Topics: Chronic Disease; Clinical Trials as Topic; Fluphenazine; Humans; Parkinson Disease; Parkinson Diseas | 1977 |
Comparison of amantadine, orphenadrine, and placebo in the control of phenothiazine-induced Parkinsonism.
Topics: Affect; Amantadine; Basal Ganglia Diseases; Clinical Trials as Topic; Evaluation Studies as Topic; F | 1972 |
Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial. Report to the Medical Research Council Committee on Clinical Trials in Psychiatry.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Chronic Disease; Clinical Trials as Topic; Delayed-Action | 1973 |
Comparison of phenothiazine and nonphenothiazine neuroleptics according to psychopathology, side effects and computerized EEG.
Topics: Alpha Rhythm; Chronic Disease; Clinical Trials as Topic; Computers; Electroencephalography; Female; | 1974 |
13 other studies available for fluphenazine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Clinical aspects of comorbid schizophrenia and idiopathic Parkinson's disease.
Topics: Antiparkinson Agents; Antipsychotic Agents; Brain; Carbidopa; Catechols; Clozapine; Diagnosis, Diffe | 2014 |
Development of parkinsonism after gradual reduction of fluphenazine dosage.
Topics: Fluphenazine; Humans; Parkinson Disease; Parkinsonian Disorders | 1963 |
Drug-induced extrapyramidal symptoms: their incidence and treatment.
Topics: Chlorpromazine; Chlorprothixene; Extrapyramidal Tracts; Female; Fluphenazine; Humans; Male; Parasymp | 1967 |
Tardive dyskinesia in psychiatric outpatients: a study of prevalence and association with demographic, clinical, and drug history variables.
Topics: Age Factors; Ambulatory Care; Antipsychotic Agents; Delayed-Action Preparations; Delusions; Dentures | 1982 |
Persistent akathisia following neuroleptic withdrawal.
Topics: Akathisia, Drug-Induced; Female; Fluphenazine; Humans; Middle Aged; Parkinson Disease | 1983 |
Neuroleptics and the corpus striatum: clinical implications.
Topics: Acetylcholine; Basal Ganglia Diseases; Benztropine; Corpus Striatum; Dopamine; Fluphenazine; Haloper | 1976 |
Neuroleptic-induced catalepsy as a model of Parkinson's disease. I. Effect of dopaminergic agents.
Topics: Animals; Antipsychotic Agents; Catalepsy; Disease Models, Animal; Dopamine; Dose-Response Relationsh | 1990 |
Neuroleptic-induced catalepsy as a model of Parkinson's disease. II. Effect of glutamate antagonists.
Topics: Animals; Antipsychotic Agents; Catalepsy; Disease Models, Animal; Dizocilpine Maleate; Fluphenazine; | 1990 |
Reactions to fluphenazine hydrochloride by two adult male macaques.
Topics: Aggression; Animals; Behavior, Animal; Drinking Behavior; Drug Tolerance; Feeding Behavior; Fluphena | 1971 |
Fluphenazine-induced parkinsonism in the baboon: pharmacological and metabolic studies.
Topics: Animals; Basal Ganglia Diseases; Benztropine; Carbon Isotopes; Chromatography, Thin Layer; Feces; Fe | 1972 |
EEG depth leads during stereotaxic brain surgery. A report on 117 cases (5 target points, effects of 13 different drugs).
Topics: Amides; Amygdala; Antimetabolites; Asparagine; Benzoates; Brain; Brain Diseases; Cerebrovascular Cir | 1970 |
The treatment of the "anxiety-tension syndrome", in Parkinson's disease with fluphenazine (Pacinol).
Topics: Adult; Aged; Anxiety; Delayed-Action Preparations; Female; Fluphenazine; Humans; Male; Middle Aged; | 1966 |
The effectiveness of parenteral administration of fluphenazine decanoate in the treatment of chronic schizophrenics.
Topics: Administration, Oral; Adult; Biperiden; Chronic Disease; Female; Fluphenazine; Humans; Infusions, Pa | 1970 |